1.
Am Heart J
; 216: 143-146, 2019 10.
Artículo
en Inglés
| MEDLINE
| ID: mdl-31053235
RESUMEN
Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and prior to a recurrent ACS event during 1 year follow-up.